These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24526746)

  • 1. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study.
    Pietrzak RH; Scott JC; Neumeister A; Lim YY; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    Br J Psychiatry; 2014; 204():400-1. PubMed ID: 24526746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study.
    Pietrzak RH; Laws SM; Lim YY; Bender SJ; Porter T; Doecke J; Ames D; Fowler C; Masters CL; Milicic L; Rainey-Smith S; Villemagne VL; Rowe CC; Martins RN; Maruff P;
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jan; 2(1):45-52. PubMed ID: 29560886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
    Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
    J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decline in episodic memory in healthy older adults with high amyloid-β.
    Lim YY; Pietrzak RH; Ellis KA; Jaeger J; Harrington K; Ashwood T; Szoeke C; Martins RN; Bush AI; Masters CL; Rowe CC; Villemagne VL; Ames D; Darby D; Maruff P
    J Alzheimers Dis; 2013; 33(3):675-9. PubMed ID: 23001710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
    Lim YY; Ellis KA; Pietrzak RH; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Neurology; 2012 Oct; 79(16):1645-52. PubMed ID: 23071163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Sectional and Prospective Associations Between β-Amyloid in the Brain and Chair Rise Performance in Nondementia Older Adults With Spontaneous Memory Complaints.
    de Souto Barreto P; Cesari M; Rolland Y; Salabert AS; Payoux P; Andrieu S; Vellas B;
    J Gerontol A Biol Sci Med Sci; 2017 Feb; 72(2):278-283. PubMed ID: 27694343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints.
    Teipel SJ; Cavedo E; Weschke S; Grothe MJ; Rojkova K; Fontaine G; Dauphinot L; Gonzalez-Escamilla G; Potier MC; Bertin H; Habert MO; Dubois B; Hampel H;
    Neurobiol Aging; 2017 Sep; 57():143-152. PubMed ID: 28646687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
    Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
    J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
    Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
    J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance.
    Harrison TM; Maass A; Baker SL; Jagust WJ
    Neurobiol Aging; 2018 Jul; 67():162-170. PubMed ID: 29665578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
    Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
    Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety symptoms predicted decline in episodic memory in cognitively healthy older adults: A 3-year prospective study.
    Fung AWT; Lee JSW; Lee ATC; Lam LCW
    Int J Geriatr Psychiatry; 2018 May; 33(5):748-754. PubMed ID: 29297937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
    Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
    Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
    Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
    PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild worry symptoms predict decline in learning and memory in healthy older adults: a 2-year prospective cohort study.
    Pietrzak RH; Maruff P; Woodward M; Fredrickson J; Fredrickson A; Krystal JH; Southwick SM; Darby D
    Am J Geriatr Psychiatry; 2012 Mar; 20(3):266-75. PubMed ID: 22354117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.